Skip to main content
CABA logo

CABA

Cabaletta Bio, Inc.

$0.94

7.03%

Trade Ideas Performance

Latest Closed Trade Idea

$0.94

7.03%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

27

Social

12

About

Events of Cabaletta Bio, Inc. (CABA)

Over the past six months, Cabaletta Bio's stock price has experienced significant volatility, declining 57.76% from $3.61 on October 31, 2025, to $1.52 on October 28, 2026, trading between a 52-week low of $1.18 and a high of $4.23. A notable event was a 40% sell-off in the stock over a month leading up to mid-October 2026, despite positive efficacy data from early Phase 1/2 cohorts for rese-cel, partly attributed to concerns about the company's cash runway. However, the company received approximately $115 million in gross proceeds from warrant exercises between July 1, 2026, and September 12, 2026, strengthening its cash position to approximately $299.4 million as of September 30, 2026, which is expected to fund operations into the first quarter of 2028. Cabaletta Bio also participated in healthcare conferences in September 2026 and announced in early November 2026 that registrational adult topline results from RESET-Myositis are anticipated in the second half of 2027, with a planned Biologics License Application submission in the first quarter of 2028.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)